by Ernie Mundell and Robin Foster In a move that should hasten the country’s recovery from the pandemic, the U.S. Food and Drug Administration on Monday approved the emergency use of Pfizer’s two-dose coronavirus vaccine for 12- to 15-year-olds. “Today’s action allows for a younger population to be protected from COVID-19, bringing us closer to...
